TY - JOUR T1 - Metabolite patterns of patients with peripheral arterial disease in response to exercise JF - medRxiv DO - 10.1101/2021.07.24.21261067 SP - 2021.07.24.21261067 AU - Tiffany R. Bellomo AU - Noah L. Tsao AU - Hillary Johnston-Cox AU - Kamil Borkowski AU - Gabrielle Shakt AU - Renae Judy AU - Jonni S. Moore AU - Sarah J. Ractcliffe AU - Oliver Fiehn AU - Emile Mohler AU - John W. Newman AU - Scott M. Damrauer Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/27/2021.07.24.21261067.abstract N2 - Supervised exercise therapy (SET) is an effective intervention for symptomatic peripheral artery disease. Its effect on metabolism, measured by the circulating metabolome is not well understood. Participants underwent the Gardner graded treadmill test before and after SET and blood was sampled before and after each treadmill test. We tested the average association of metabolite levels with timing of blood draws. We used five models to identify metabolites or changes in metabolites at specific time points that associate with treadmill test performance or inter-individual variability in functional performance after SET. When analyzing individual time points, high levels of anandamide (AEA) before any exercise interventions were associated with shorter, or worse, walking time. Increased arachidonic acid (AA) and decreased levels of AA precursors (dihomo-γ-linolenic acid and diacylglycerol) before any exercise was associated with shorter walking times. Participants who tolerated large increases in AA during acute exercise had longer, or better, walking times before and after SET. We identified two pathways of relevance to individual response to SET: AEA synthesis may increase the activity at endocannabinoid receptors, resulting in worse treadmill test performance. SET may help train patients withstand higher levels of AA and inflammatory signaling, resulting in longer walking times.Competing Interest StatementS.M.D. receives research support to his institution from CytoVAS, LLC and RenalytixAI and consulting fees from Calico Labs, all outside the scope of the current work. All other authors have no conflicts of interest to declare.Clinical TrialData was obtained from a previously published clinical trial NCTID 2RO1HL075649-06A2.Funding StatementThis research supported by NIH NCATS UL1TR000003. S.M.D was also supported by funding from the Department of Veterans Affairs IK2-CD001780. The authors wish to thank patient participants; without their assistance, this research would not have been possible. This publication does not represent the views of the Department of Veterans Affairs, the US Food and Drug Administration, or the US Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed by the University of Pennsylvania Institutional Review Board for Human Subjects Research. All participants provided written informed consent prior to inclusion in this study: NCTID 2RO1HL075649-06A2.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAdditional data that were used to generate the Figures in this study are available on request from the corresponding author (S.M.D.) ER -